跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAR-DILTIAZEM CD - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MAR-DILTIAZEM CD
Authorized
STANDARD
MAR-DILTIAZEM CD
marcan pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c066d446322b08b4
Company
marcan pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
c066d446322b08b4
Drug Approval Canada Name
MAR-DILTIAZEM CD
Product Name
MAR-DILTIAZEM CD
Status
Marketed
Status Date
2020-03-30
Original Market Date
2020-03-30
Din
02484072
Drug Class
Human
Dosage Form
Capsule (Controlled-Delivery)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:28.92
Atc Original
C08DB01 DILTIAZEM
Atc Name
c 08 db 01
Aig Number
0115863007
Company Name
marcan pharmaceuticals inc
Company Address
2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2
Active Ingredients
DILTIAZEM HYDROCHLORIDE
180 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c066d446322b08b4
Type
Standard
Back to Health Canada Approvals